Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma

Oh, IJ; Hur, JY; Park, CK; Kim, YC; Kim, SJ; Lee, MK; Kim, HJ; Lee, KY; Lee, JC; Choi, CM

Choi, CM (reprint author), Univ Ulsan, Dept Pulm & Crit Care Med, Dept Oncol, Aran Med Ctr,Coll Med, 86 Asanbyeongwon Gil, Seoul 138736, South Korea.

CLINICAL LUNG CANCER, 2018; 19 (5): E775

Abstract

HER2 mutations are found in 2% to 4% of non-small-cell lung cancer and are usually mutually exclusive with other genetic alterations. In this study, t......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索